{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:37:51Z","timestamp":1789994271622,"version":"4.0.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:00:00Z","timestamp":1497398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0179025","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T13:38:38Z","timestamp":1497447518000},"page":"e0179025","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hepatitis B testing and treatment in HIV patients in The Gambia\u2014Compliance with international guidelines and clinical outcomes"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5837-5110","authenticated-orcid":true,"given":"Gibril","family":"Ndow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy L.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shimakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penda","family":"Suso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulie","family":"Jatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saydiba","family":"Tamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Sow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coumba","family":"Tour\u00e9-Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saihou","family":"Sabally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramou","family":"Njie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Thursz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"issue":"Issue 10003","key":"ref1","first-page":"1546","article-title":"Estimations of worldwide prevalence of chronic hepatitis B infection: a systematic review of data published between 1965 and 2013","volume":"Vol 386","author":"A Schweitzer","year":"2015"},{"key":"ref2","first-page":"1081","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"JD Stanaway","year":"2016"},{"key":"ref3","article-title":"<italic>Combatting Hepatitis B and C to reach elimination by 2030<\/italic>","year":"2016"},{"key":"ref4","unstructured":"World Health Organisation. WHA 67.6 Hepatitis. In: Sixty-Seventh World Health Assembly. 24th May 2014, Geneva, Switzerland."},{"key":"ref5","unstructured":"United Nations. Transforming our World: The 2030 Agenda for Sustainable Development. United Nations, 2015"},{"key":"ref6","unstructured":"United Nations. Sustainable Development Goal 3 \u2013Ensure healthy lives and promote well-being for all at all ages. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/sustainabledevelopment.un.org\/sdg3\" xlink:type=\"simple\">https:\/\/sustainabledevelopment.un.org\/sdg3<\/ext-link>"},{"key":"ref7","article-title":"<italic>Global Health Sector Strategy on Viral Hepatitis 2016\u20132021<\/italic>","year":"2015"},{"key":"ref8","article-title":"Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations","year":"2016"},{"key":"ref9","article-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","year":"2013"},{"key":"ref10","first-page":"S274","article-title":"Prevalence of HIV and Hepatitis B Virus Co-Infection in sub-Saharan Africa and the potential impact and program feasibility of Hepatitis B surface antigen screening in resource-limited settings","volume":"68","author":"L Stabinski","year":"2015"},{"key":"ref11","unstructured":"Kouam\u00e9 MG, Moh R, Boyd A, Badj\u00e9 A, Gabillard D, N\u2019takp\u00e9 JB, et al. Higher mortality in HIV-HBV co-infected persons with elevated HBV replication in the Temprano Trial. [WEAB0303]. Presented at: 21st International AIDS Conference, 18\u201322 July 2016; South Africa."},{"key":"ref12","unstructured":"Japhet MM, Ndhere A, Ndwiga S, Kirwa E, Yogev R, Murphy R, et al. Early mortality risk of HIV\/Hepatitis B virus coinfected patients initiating ART [Abstract Number 562]. Presented at: Conference on Retroviruses and Opportunistic Infections (CROI), 2016; Boston, Massachusetts."},{"issue":"Issue 8","key":"ref13","first-page":"e559","article-title":"Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study","volume":"Vol 4","author":"M Lemoine","year":"2016"},{"key":"ref14","first-page":"658","article-title":"Evaluation of data quality at the Gambia National Cancer Registry","volume":"132","author":"Y Shimakawa","year":"2013"},{"issue":"1","key":"ref15","first-page":"211","article-title":"The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa","volume":"39","author":"GD Kirk","year":"2004"},{"issue":"11","key":"ref16","first-page":"897","article-title":"Implementation of an in-house quantitative real-time polymerase chain reaction method for hepatitis B virus quantification in West African countries","volume":"23","author":"S Ghosh","year":"2016"},{"key":"ref17","article-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","year":"2015"},{"key":"ref18","first-page":"548","article-title":"A new scoring system for prediction of fibrosis in chronic hepatitis C","volume":"11","author":"S Bota","year":"2011"},{"issue":"1\u20132","key":"ref19","first-page":"207","article-title":"Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control","volume":"126","author":"JA Garson","year":"2005"},{"issue":"suppl_2","key":"ref20","first-page":"W654","article-title":"A web-based genotyping resource for viral sequences","volume":"32","author":"M Rozanov","year":"2004"},{"issue":"1","key":"ref21","first-page":"22","article-title":"Efficacy and tolerance of tenofovir-lamivudine-efavirenz combination in HIV-1 patients in Fann Teaching Hospital in Dakar","volume":"106","author":"SA Diop","year":"2013"},{"key":"ref22","article-title":"<italic>Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in The Gambia<\/italic>","year":"2015"},{"issue":"Issue 6","key":"ref23","first-page":"1714","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"Volume 125","author":"ASF Lok","journal-title":"Gastroenterology"},{"key":"ref24","first-page":"561","article-title":"Emergence of HBV resistance to lamivudine (3TC) in HIV\/HBV co-infected patients in The Gambia, West Africa","volume":"4","author":"B Stewart","year":"2011"},{"issue":"6","key":"ref25","first-page":"883","article-title":"Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana","volume":"15","author":"AJ Stockdale","year":"2015"},{"issue":"6","key":"ref26","first-page":"643","article-title":"Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from C\u00f4te d&apos;Ivoire","volume":"20","author":"A Boyd","year":"2015"},{"issue":"3","key":"ref27","first-page":"405","article-title":"High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda","volume":"16","author":"L Stabinski","year":"2011"},{"issue":"12","key":"ref28","first-page":"e189","article-title":"Assessment of liver fibrosis by transient elastography in patients with HIV and hepatitis B virus coinfection in Nigeria","volume":"57","author":"C Hawkins","year":"2013"},{"key":"ref29","first-page":"1435","article-title":"Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia","volume":"21","author":"MJ Vinikoor","year":"2016"},{"issue":"3","key":"ref30","first-page":"ofw162","article-title":"Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort","volume":"3","author":"A Ram\u00edrez-Mena","year":"2016"},{"key":"ref31","first-page":"22","article-title":"High Prevalence of Liver Fibrosis in Patients with Human Immunodeficiency Virus Monoinfection and Human Immunodeficiency Virus Hepatitis-B Co-infection as Assessed by Shear Wave Elastography: Study at a Teaching Hospital in Kenya","volume":"6","author":"SN Gitau","year":"2016"},{"key":"ref32","first-page":"1886","article-title":"Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia","volume":"35","author":"MJ Vinikoor","year":"2015"},{"key":"ref33","first-page":"21426","article-title":"Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with Tenofovir Disoproxil Fumarate in France: a prospective cohort study","volume":"20","author":"A Boyd","year":"2017"},{"key":"ref34","first-page":"2059","article-title":"Is aspartate aminotransferase-to-platelet ratio index a reliable tool in human immunodeficiency virus patients in Africa?","volume":"35","author":"A Johannessen","year":"2015"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0179025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T07:22:20Z","timestamp":1540279340000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0179025"}},"subtitle":[],"editor":[{"given":"Isabelle A","family":"Chemin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,14]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0179025","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,14]]}}}